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Biotechnology and information technology industries are acknowledged as the 
two high-new technology pillar industries in 21st century. Biopharmaceutics, the most 
vigorous and fast growing field in biotechnology, are highly appreciated by venture 
capital in western countries.  
China’s biopharmaceutics and venture capitals are all new sunrise industries 
which develop in recent years. They are immature in every respect. The current 
development situation of biopharmaceutics displays its urgency of getting help from 
venture capital. 
This article uses SWOT tool to analyze the strengths and weaknesses for venture 
capital to invest in biopharmaceutics: venture capital could help Chinese 
biopharmaceutics companies to solve the difficulties of funding and lack of 
operational talents; otherwise, the immature Venture Capital, without very good 
policies makes itself to act more actively. The characteristics of biopharmaceutics 
industry coincide with the investing concept of VC. This article not only shows 
venture capital’s great role in boosting biopharmaceutics, but also tells that 
biopharmaceutics industry deserves highly attention for venture capital. 
In USA, the biopharmaceutics industry has surpassed IT industry to accept the 
most investments by venture capital. However, the main investments are still focus on 
industries such as IT and traditional service. And the investigations on Venture Capital 
are almost based on IT industry. There are few articles which specialize in the 
biopharmaceutics industry. 
High input, high return, high risk, long development cycle and being strictly 
monitored by countries, are features of biopharmaceutics industry. The characteristics 
and the law of development of the biopharmaceutics industry is quite different from 
IT industry. If the VC investors make the investments on the biopharmaceutics 
companies based on their experiences and methods they learn from IT industry, they 















This article focuses on analyzing the differences of the features between 
biopharmaceutics and IT industries. It also approaches the proper venture capital 
operating manner which is adapting to the law of development of biotechnology, such 
as to build up professional fund for the biopharmaceutics industry, to help the 
companies seek for CRO strategy alliance and so on. These could provide some 
references for venture capital institutes investing in biopharmaceutics industry.  
 
 















目  录 
第一章  绪论 ............................................................................................1 
第一节  选题背景与研究目的 ..........................................................................1 
第二节  主要内容和框架 ..................................................................................2 
第二章  生物制药行业概述 ....................................................................3 
第一节  生物制药的相关概念 ..........................................................................3 
第二节  生物制药行业的特点 ..........................................................................6 
第三节  生物制药行业的发展现状 ................................................................10 
第四节  我国生物制药行业的发展困境 ........................................................16 
第三章  风险投资概述 ..........................................................................20 
第一节  风险投资的定义 ................................................................................20 
第二节  风险投资的特点 ................................................................................21 
第三节  国内外风险投资行业发展现状 ........................................................22 
第四章  对我国生物制药行业风险投资的 SWOT 分析 ....................31 
第一节  优势 ....................................................................................................31 
第二节  劣势 ....................................................................................................34 
第三节  机会 ....................................................................................................37 
第四节  威胁 ....................................................................................................40 
第五节  分析结论 ............................................................................................41 
第五章  我国生物制药行业风险投资的运作分析 ..............................43 
第一节  前期准备阶段 ....................................................................................43 
第二节  投资目标的筛选 ................................................................................44 
第三节  投资时机与投资方式分析 ................................................................47 
第四节  增值服务 ............................................................................................49 
第五节  风险控制 ............................................................................................52 
第六节  退出之道 ............................................................................................54 















第一节  结论 ....................................................................................................60 


















Chapter1  Introduction ..........................................................................1 
Section1  Background and Significance..........................................................1 
Section2  Thought and Framework.................................................................2 
Chapter2  Summarization of Biopharmaceutics .................................3 
Section1  Concepts of Biopharmaceutics ........................................................3 
Section2  Characteristics of Biopharmaceutics..............................................6 
Section3  The Present Situation of Biopharmaceutics.................................10 
Section4  Problems of Biopharmaceutics in China......................................16 
Chapter3  Summarization of Venture Capital...................................20 
Section1  Definition of Venture Capital ........................................................20 
Section2  Characteristics of Venture Capital ...............................................21 
Section3  The present Situation of Venture Capital ....................................22 
Chapter4  The Analysis of Venture Capital in China’s 
Biopharmaceutics Using SWOT Method .............................................31 
Section1  Strength ...........................................................................................31 
Section2  Weakness .........................................................................................34 
Section3  Opportunity.....................................................................................37 
Section4  Threat ..............................................................................................40 
Section5  Conclusion .......................................................................................41 
Chapter5  The Operation of Venture Capital in China’s 
Biopharmaceutics....................................................................................43 
Section1  Preparation Stage ...........................................................................43 
Section2  Sieving Out Targets........................................................................44 
Section3  Suitable Time and Modes of Investment ......................................47 















Section5  Risk Management...........................................................................52 
Section6  Ways of Quit ...................................................................................54 
Chapter6  Conclusion and Advices .....................................................60 
Section1  Conclusion .......................................................................................60 



















- 1 - 
第一章  绪论 
自从 DNA 重组技术得以成功应用以来,生物技术得到了迅速的发展。得益
于技术的突破，生物技术产业近 10 年来，正在全世界范围迅速成长，在西方国
家生物技术相关产业（含医疗、农业、工业的某些部分）一般占 GDP 的 20%～
30%。据统计，60%以上的生物技术成果被用于医药行业[18]。 






术含量最高的领域。从 1998 年开始，全球生物制药产业的年销售额连续 10 年增
长速度保持在 15%~33%，成为发展最快的高技术产业之一。2007 年仅基因工程
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